Cargando…

A Combination of circRNAs as a Diagnostic Tool for Discrimination of Papillary Thyroid Cancer

BACKGROUND AND AIM: Circular RNAs (circRNAs) have been highlighted to exert essential biological functions in papillary thyroid cancer (PTC). The purpose of this study was explore diagnostic utility of circRNAs in PTC patients. PATIENTS AND METHODS: The distinctive expression profile of serum circR...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Erlan, Ye, Jun, Zhang, Rong, Ye, Shuai, Zhang, Suwan, Wang, Yunsheng, Cao, Yonghong, Dai, Wu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245466/
https://www.ncbi.nlm.nih.gov/pubmed/32547069
http://dx.doi.org/10.2147/OTT.S247796
_version_ 1783537765496913920
author Shi, Erlan
Ye, Jun
Zhang, Rong
Ye, Shuai
Zhang, Suwan
Wang, Yunsheng
Cao, Yonghong
Dai, Wu
author_facet Shi, Erlan
Ye, Jun
Zhang, Rong
Ye, Shuai
Zhang, Suwan
Wang, Yunsheng
Cao, Yonghong
Dai, Wu
author_sort Shi, Erlan
collection PubMed
description BACKGROUND AND AIM: Circular RNAs (circRNAs) have been highlighted to exert essential biological functions in papillary thyroid cancer (PTC). The purpose of this study was explore diagnostic utility of circRNAs in PTC patients. PATIENTS AND METHODS: The distinctive expression profile of serum circRNAs was determined by individual quantitative real-time PCR (qRT-PCR) in two independent cohorts of 113 PTC patients, 80 thyroid nodules, and 111 healthy controls (HCs). A combination of circRNAs (circRNA-based combination index) was constructed by logistic regression. RESULTS: Individual qRT-PCR identification showed that two circRNAs (circRAPGEF5 and hsa_circ_0058124) were significantly up-regulated in PTC patients compared with HCs and thyroid nodules. Receiver-operating characteristic (ROC) curve analysis suggested that a combination of circRNAs was superior to individual circRNA in distinguishing PTC patients from HCs and thyroid nodules with area under ROC curve of more than 0.80. Furthermore, the combination of circRNAs increased significantly after systematic treatment, suggesting that it could monitor PTC dynamics. Additionally, the combination of circRNAs was independently correlated with PTC presence. CONCLUSION: The combination of these altered circRNAs was correlated with PTC and may serve as a novel diagnostic approach.
format Online
Article
Text
id pubmed-7245466
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-72454662020-06-15 A Combination of circRNAs as a Diagnostic Tool for Discrimination of Papillary Thyroid Cancer Shi, Erlan Ye, Jun Zhang, Rong Ye, Shuai Zhang, Suwan Wang, Yunsheng Cao, Yonghong Dai, Wu Onco Targets Ther Original Research BACKGROUND AND AIM: Circular RNAs (circRNAs) have been highlighted to exert essential biological functions in papillary thyroid cancer (PTC). The purpose of this study was explore diagnostic utility of circRNAs in PTC patients. PATIENTS AND METHODS: The distinctive expression profile of serum circRNAs was determined by individual quantitative real-time PCR (qRT-PCR) in two independent cohorts of 113 PTC patients, 80 thyroid nodules, and 111 healthy controls (HCs). A combination of circRNAs (circRNA-based combination index) was constructed by logistic regression. RESULTS: Individual qRT-PCR identification showed that two circRNAs (circRAPGEF5 and hsa_circ_0058124) were significantly up-regulated in PTC patients compared with HCs and thyroid nodules. Receiver-operating characteristic (ROC) curve analysis suggested that a combination of circRNAs was superior to individual circRNA in distinguishing PTC patients from HCs and thyroid nodules with area under ROC curve of more than 0.80. Furthermore, the combination of circRNAs increased significantly after systematic treatment, suggesting that it could monitor PTC dynamics. Additionally, the combination of circRNAs was independently correlated with PTC presence. CONCLUSION: The combination of these altered circRNAs was correlated with PTC and may serve as a novel diagnostic approach. Dove 2020-05-19 /pmc/articles/PMC7245466/ /pubmed/32547069 http://dx.doi.org/10.2147/OTT.S247796 Text en © 2020 Shi et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Shi, Erlan
Ye, Jun
Zhang, Rong
Ye, Shuai
Zhang, Suwan
Wang, Yunsheng
Cao, Yonghong
Dai, Wu
A Combination of circRNAs as a Diagnostic Tool for Discrimination of Papillary Thyroid Cancer
title A Combination of circRNAs as a Diagnostic Tool for Discrimination of Papillary Thyroid Cancer
title_full A Combination of circRNAs as a Diagnostic Tool for Discrimination of Papillary Thyroid Cancer
title_fullStr A Combination of circRNAs as a Diagnostic Tool for Discrimination of Papillary Thyroid Cancer
title_full_unstemmed A Combination of circRNAs as a Diagnostic Tool for Discrimination of Papillary Thyroid Cancer
title_short A Combination of circRNAs as a Diagnostic Tool for Discrimination of Papillary Thyroid Cancer
title_sort combination of circrnas as a diagnostic tool for discrimination of papillary thyroid cancer
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245466/
https://www.ncbi.nlm.nih.gov/pubmed/32547069
http://dx.doi.org/10.2147/OTT.S247796
work_keys_str_mv AT shierlan acombinationofcircrnasasadiagnostictoolfordiscriminationofpapillarythyroidcancer
AT yejun acombinationofcircrnasasadiagnostictoolfordiscriminationofpapillarythyroidcancer
AT zhangrong acombinationofcircrnasasadiagnostictoolfordiscriminationofpapillarythyroidcancer
AT yeshuai acombinationofcircrnasasadiagnostictoolfordiscriminationofpapillarythyroidcancer
AT zhangsuwan acombinationofcircrnasasadiagnostictoolfordiscriminationofpapillarythyroidcancer
AT wangyunsheng acombinationofcircrnasasadiagnostictoolfordiscriminationofpapillarythyroidcancer
AT caoyonghong acombinationofcircrnasasadiagnostictoolfordiscriminationofpapillarythyroidcancer
AT daiwu acombinationofcircrnasasadiagnostictoolfordiscriminationofpapillarythyroidcancer
AT shierlan combinationofcircrnasasadiagnostictoolfordiscriminationofpapillarythyroidcancer
AT yejun combinationofcircrnasasadiagnostictoolfordiscriminationofpapillarythyroidcancer
AT zhangrong combinationofcircrnasasadiagnostictoolfordiscriminationofpapillarythyroidcancer
AT yeshuai combinationofcircrnasasadiagnostictoolfordiscriminationofpapillarythyroidcancer
AT zhangsuwan combinationofcircrnasasadiagnostictoolfordiscriminationofpapillarythyroidcancer
AT wangyunsheng combinationofcircrnasasadiagnostictoolfordiscriminationofpapillarythyroidcancer
AT caoyonghong combinationofcircrnasasadiagnostictoolfordiscriminationofpapillarythyroidcancer
AT daiwu combinationofcircrnasasadiagnostictoolfordiscriminationofpapillarythyroidcancer